Publication:
Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice

cris.virtual.author-orcid0000-0002-2418-6474
cris.virtual.author-orcid0000-0002-2049-7769
cris.virtualsource.author-orcidcc7d784f-018e-4328-8471-2af746cc765e
cris.virtualsource.author-orcid321640ec-cf53-4645-899f-4799c389b32b
cris.virtualsource.author-orcid4454fc4a-eccf-4261-9624-482c41190583
cris.virtualsource.author-orcidfe74547e-3739-4ea8-ac81-baad9000ff19
cris.virtualsource.author-orcid350d8e59-fb26-4987-815c-7706769a76f1
datacite.rightsopen.access
dc.contributor.authorHilty, Markus
dc.contributor.authorWüthrich, Tsering Monika
dc.contributor.authorGodel, Aurélie
dc.contributor.authorAdelfio, Roberto
dc.contributor.authorAebi, Susanne
dc.contributor.authorBurgener, Sabrina S.
dc.contributor.authorIllgen-Wilcke, Brunhilde
dc.contributor.authorBenarafa, Charaf
dc.date.accessioned2024-10-05T11:57:23Z
dc.date.available2024-10-05T11:57:23Z
dc.date.issued2020-12
dc.description.abstractEnvironmental factors, such as cigarette smoking or lung infections, may influence chronic obstructive pulmonary disease (COPD) progression by modifying the respiratory tract microbiome. However, whether the disease itself induces or maintains dysbiosis remains undefined. In this longitudinal study, we investigated the oropharyngeal microbiota composition and disease progression of mice (in cages of 5-10 mice per cage) before, during and up to 3 months after chronic cigarette smoke exposure or exposure to room air for 6 months. Cigarette smoke exposure induced pulmonary emphysema measurable at the end of exposure for 6 months, as well as 3 months following smoke exposure cessation. Using both classical culture methods and 16S rRNA sequencing, we observed that cigarette smoke exposure altered the relative composition of the oropharyngeal microbiota and reduced its diversity (P <0.001). More than 60 taxa were substantially reduced after 6 months of smoke exposure (P <0.001) However, oropharyngeal microbiota disordering was reversed 3 months after smoke exposure cessation and no significant difference was observed compared to age-matched control mice. The effects of lung infection with Streptococcus pneumoniae on established smoke-induced emphysema and on the oropharyngeal microbiota were also evaluated. Inoculation with S. pneumoniae induced lung damage and altered the microbiota composition for a longer time compared to control groups infected but not previously exposed to smoke (P=0.01). Our data demonstrate effects of cigarette smoke and pneumococcus infection leading to altered microbiota and emphysema development. The reversal of the disordering of the microbiota composition, but not lung damage, following smoke exposure cessation and after clearance of infection suggest that changes in lung structure are not sufficient to sustain a disordered microbiota in mice. Whether changes in the airway microbiota contribute to inducing emphysema requires further investigation.
dc.description.sponsorshipInstitut für Infektionskrankheiten, Forschung
dc.description.sponsorshipInstitut für Virologie und Immunologie (IVI)
dc.identifier.doi10.7892/boris.149466
dc.identifier.pmid33295863
dc.identifier.publisherDOI10.1099/mgen.0.000485
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/55776
dc.language.isoen
dc.publisherMicrobiology Society
dc.relation.ispartofMicrobial genomics
dc.relation.issn2057-5858
dc.relation.organizationDCD5A442BA19E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD12E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C0BAE17DE0405C82790C4DE2
dc.relation.schoolDCD5A442C27BE17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::630 - Agriculture
dc.subject.ddc500 - Science::570 - Life sciences; biology
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleChronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.issue12
oaire.citation.volume6
oairecerif.author.affiliationInstitut für Infektionskrankheiten, Forschung
oairecerif.author.affiliationInstitut für Infektionskrankheiten, Forschung
oairecerif.author.affiliationInstitut für Virologie und Immunologie (IVI)
oairecerif.author.affiliationInstitut für Infektionskrankheiten, Forschung
oairecerif.author.affiliationInstitut für Virologie und Immunologie (IVI)
oairecerif.author.affiliation2Institut für Infektionskrankheiten (IFIK)
oairecerif.author.affiliation2Institut für Infektionskrankheiten (IFIK)
oairecerif.author.affiliation2Institut für Infektionskrankheiten (IFIK)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2020-12-18 13:29:07
unibe.description.ispublishedpub
unibe.eprints.legacyId149466
unibe.journal.abbrevTitleMicrob Genom
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
mgen000485.pdf
Size:
5.62 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections